The small bowel enteroscope market is currently estimated to be valued at US$ 500 Million, at a steady CAGR of 8% to 9% over the forecast period (2022 to 2032). Sales in the small bowel enteroscope market are anticipated to record substantial growth over the upcoming decade.
Adoption of small bowel enteroscope will presumably rise due to provisions like interventional and visualization therapy provided by the enteroscope. Small bowel enteroscopes also provide high-quality images of the entire bowel as compared to other techniques and devices. This will bolster the demand in the small bowel enteroscope market from 2022 to 2032.
| Report Attribute | Details |
|---|---|
| Small Bowel Enteroscope Market Size (2022) | US$ 500 Million |
| Small Bowel Enteroscope Market Projected Growth Rate (2022 to 2032) | 8% to 9% CAGR |
Enteroscopy is a medical diagnostic procedure- a type of endoscopy- used to diagnose a variety of medical conditions of the digestive tract. Enteroscope, a device used for endoscopy, constitutes a thin, flexible tube with an attached camera at the tip.
This enteroscope is then inserted either through the mouth or rectum for diagnosis and treatment of disorders of the small bowel. Generally, one or two inflatable balloons are attached to the device. These balloons aid the device to get a closer view of the esophagus, stomach, and small intestine.
Increasing demand for improved diagnosis and treatment of bowel disorders has led to technological advancements in the field of endoscopy. As such, small bowel enteroscope plays an important role in the diagnosis and evaluation of bowel disorders and examination of gastrointestinal tracts.
Small bowel enteroscope has also been acknowledged and applied for a wide variety of indications.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising demand for accurate and improved diagnosis and treatment for gastrointestinal disorders along with advancing technologies will bolster the growth in the small bowel enteroscope market. Further, small bowel enteroscopes are accepted for a wide range of indications including obscure gastrointestinal bleeding, small bowel tumors, polyposis syndromes, and others.
Certain indications currently under investigation are Crohn’s disease, refractory celiac disease, and small bowel obstruction. The rising prevalence of these diseases will aid the growth of the small bowel enteroscope market.
Surging cases of gastrointestinal disorders and gastrointestinal bleeding in patients will also boost the adoption of small bowel enteroscopes in hospitals, clinics, and diagnostics laboratories. This will further contribute to the growth of the global small bowel enteroscope market.
The high cost of enteroscope in emerging economies is one of the key factors limiting the growth of the small bowel enteroscope market
The small bowel enteroscopes require skilled professionals trained in the medicine and study of enteroscope to perform the examination. Hence, the dearth of trained professionals might impede growth.
Besides this, small bowel enteroscopes require a prolonged time to perform the examination which makes medical professionals reluctant to opt for enteroscope. Hence, the availability of alternative options to enteroscope might hinder sales.
Principal Consultant
Technological advancements, a rise in demand for more sophisticated diagnoses of gastrointestinal disorders, and an upsurge in applications of small bowel enteroscopes are anticipated to fuel the growth of the small bowel enteroscope market in the Asia Pacific.
The small bowel enteroscope market is expected to grow at a significant growth rate in Asia Pacific. This is owing to the increasing number of bowel disorders in densely populated countries such as India and China.
Swiftly changing healthcare systems and policies, certain government initiatives to improve healthcare and higher per capita healthcare expenditure are likely to propel small bowel enteroscope market growth in Asia Pacific.
The high prevalence of gastrointestinal disorders especially inflammatory bowel syndrome will drive the market for small bowel enteroscope. According to the Centers for Disease Control (CDC) and Prevention, an estimated 3 million USA adults were reported to be diagnosed with inflammatory bowel syndrome in 2015.
This, growing awareness about gastrointestinal disorders, access to advanced healthcare facilities, and increasing investments in the healthcare sector will boost the small bowel enteroscope market in North America.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Leading players present in the global small bowel enteroscope market include Pentax Medical, Olympus Corporation, and FUJIFILM Holdings America Corporation among others.
The market is fairly competitive with key companies in the market engaged in developing their portfolio of new enteroscope products and adopting a commercialization strategy. Leading manufacturers are currently carrying out multiple clinical trials related to other indications of small bowel enteroscope to expand their product portfolio and strengthen their position in the market.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8 to 9% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Million, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Indication, End User, Region |
| Countries Covered | North America (USA, Canada); Latin America (Mexico, Brazil); Western Europe (Germany, Italy, France, United Kingdom, Spain, Nordic countries, Belgium, Netherlands, Luxembourg); Eastern Europe (Poland, Russia); Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand); Japan; The Middle East and Africa (GCC, S. Africa, N. Africa) |
| Key Companies Profiled | Pentax Medical; Olympus Corporation; FUJIFILM Holdings America Corporation |
| Customization | Available Upon Request |
Owing to the expansion of healthcare infrastructure and improved healthcare expenditure, North America will lead the growth in the small bowel enteroscopes market
Leading players present in the global small bowel enteroscope market include Pentax Medical, Olympus Corporation, and FUJIFILM Holdings America Corporation among others.
Rising demand for sophisticated diagnosis and treatment of gastrointestinal disorders along with advancing technologies are factors positively influencing the growth of the small bowel enteroscope market
1. Executive Summary | Small Bowel Enteroscopes Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Indication
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2022 to 2032
5.3.1. Obscure Gastrointestinal Bleeding
5.3.2. Small Bowel Tumours
5.3.3. Polyposis Syndromes
5.3.4. Dilation of Small Bowel Stenosis
5.4. Y-o-Y Growth Trend Analysis By Indication, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Indication, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Diagnostics Laboratories
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Indication
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Indication
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Indication
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Indication
9.3.3. By End User
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. United Kingdom
10.2.1.5. Russia
10.2.1.6. BENELUX
10.2.1.7. Rest of Europe
10.2.2. By Indication
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Indication
10.3.3. By End User
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Rest of Asia Pacific
11.2.2. By Indication
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Indication
11.3.3. By End User
11.4. Key Takeaways
12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Turkey
12.2.1.4. Rest of Middle East and Africa
12.2.2. By Indication
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Indication
12.3.3. By End User
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. USA
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Indication
13.1.2.2. By End User
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Indication
13.2.2.2. By End User
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Indication
13.3.2.2. By End User
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Indication
13.4.2.2. By End User
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Indication
13.5.2.2. By End User
13.6. Italy
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Indication
13.6.2.2. By End User
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Indication
13.7.2.2. By End User
13.8. United Kingdom
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Indication
13.8.2.2. By End User
13.9. Russia
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Indication
13.9.2.2. By End User
13.10. BENELUX
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Indication
13.10.2.2. By End User
13.11. China
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Indication
13.11.2.2. By End User
13.12. Japan
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Indication
13.12.2.2. By End User
13.13. South Korea
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Indication
13.13.2.2. By End User
13.14. GCC Countries
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Indication
13.14.2.2. By End User
13.15. South Africa
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Indication
13.15.2.2. By End User
13.16. Turkey
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Indication
13.16.2.2. By End User
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Indication
14.3.3. By End User
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Pentax Medical
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Olympus Corporation
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. FUJIFILM Holdings America Corporation.
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports
Small Bowel Enteroscopes Market
